DIUMIDE-K Tablets 40mg, 600m %v/v
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
24-03-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FUROSEMIDE POTASSIUM CHLORIDE
Available from:
Napp Pharmaceuticals Limited
Dosage:
40mg, 600m %v/v
Pharmaceutical form:
Tablets
Authorization date:
1998-01-04
Summary of Product characteristics
License
Part II
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Diumide-K Continus prolonged release, film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Furosemide 40 mg
Potassium Chloride 600 mg (prolonged release).
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Prolonged release, film-coated tablets.
Orange/white, film coated, bi-layered tablets with the letters ‘DK’ on the orange coloured layer.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
In the management of fluid retention in which potassium supplementation is required in support of a diuretic
administered daily, in mild to moderate hypertension, and in oedema of various aetiologies.
4.2 Posology and method of adminstration
Route of Administration
Oral.
Adults only
The usual dosage is one tablet daily.
4.3 Contraindications
1.
Use of the combination in the presence of hyperkalaemia, precoma associated with hepatic
cirrhosis, or Addison’s disease.
2.
Use in children.
3.
Hypersensitivity to furosemide, potassium chloride or any other constituent of the tablets.
4. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or
glucose-galactose malabsorption should not take this medicine.
Irish Medicines Board
______________________________________________________________________________________________________________________
Date Issued 10/08/2005
CRN 2012
Read the complete document
